Covered recipient · General Payments record
BROCK HOLSTON MARRS
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2021–2024
$8,533.71
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $866.36 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.05 | 22 |
| SPR Therapeutics, Inc | $226.12 | 5 |
| Nevro Corp. | $144.46 | 1 |
| TerSera Therapeutics LLC | $120.82 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $30.50 | 1 |
| Pacira Pharmaceuticals Incorporated | $25.68 | 1 |
| PIRAMAL CRITICAL CARE | $20.19 | 1 |
| Medtronic, Inc. | $15.77 | 1 |
| Vertos Medical, Inc. | $6.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.68 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970599 | CMS |
| ABBVIE INC. | $13.34 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970601 | CMS |
| ABBVIE INC. | $5.11 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970603 | CMS |
| ABBVIE INC. | $19.83 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970605 | CMS |
| ABBVIE INC. | $16.26 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970607 | CMS |
| ABBVIE INC. | $14.99 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970609 | CMS |
| ABBVIE INC. | $18.58 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970611 | CMS |
| ABBVIE INC. | $10.16 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970613 | CMS |
| ABBVIE INC. | $15.56 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970615 | CMS |
| ABBVIE INC. | $3.02 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970617 | CMS |
| ABBVIE INC. | $9.08 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970619 | CMS |
| ABBVIE INC. | $13.65 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970621 | CMS |
| ABBVIE INC. | $3.04 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970623 | CMS |
| ABBVIE INC. | $12.06 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970625 | CMS |
| ABBVIE INC. | $10.07 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970627 | CMS |
| ABBVIE INC. | $15.76 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970629 | CMS |
| ABBVIE INC. | $12.23 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970631 | CMS |
| ABBVIE INC. | $18.06 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970633 | CMS |
| ABBVIE INC. | $7.75 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970635 | CMS |
| ABBVIE INC. | $16.87 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970637 | CMS |
| ABBVIE INC. | $18.10 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970639 | CMS |
| ABBVIE INC. | $10.85 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104970641 | CMS |
| Boston Scientific Corporation | $30.50 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092485149 | CMS |
| Medtronic, Inc. | $15.77 | 07/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119422823 | CMS |
| Nevro Corp. | $144.46 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130757514 | CMS |
| Pacira Pharmaceuticals Incorporated | $25.68 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151240977 | CMS |
| PIRAMAL CRITICAL CARE | $20.19 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144461176 | CMS |
| SPR Therapeutics, Inc | $80.81 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104951929 | CMS |
| SPR Therapeutics, Inc | $35.38 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104930183 | CMS |
| SPR Therapeutics, Inc | $21.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104930247 | CMS |
| SPR Therapeutics, Inc | $57.35 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104930311 | CMS |
| SPR Therapeutics, Inc | $30.67 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104930375 | CMS |
| TerSera Therapeutics LLC | $120.82 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144713315 | CMS |
| Vertos Medical, Inc. | $6.77 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133350016 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.